Prognostic factors for patients with advanced thoracic esophageal squamous cell carcinoma receiving preoperative cisplatin plus 5-fluorouracil (JCOG9907).
Tomoya Yokota
Honoraria - Merck; Merck Serono
Nobutoshi Ando
No relevant relationships to disclose
Hiroyasu Igaki
No relevant relationships to disclose
Masayuki Shinoda
No relevant relationships to disclose
Ken Kato
Research Funding - Daiichi Sankyo; Shionogi
Yuko Kitagawa
Research Funding - Nippon Kayaku
Junki Mizusawa
No relevant relationships to disclose
Hiroshi Katayama
No relevant relationships to disclose
Kenichi Nakamura
No relevant relationships to disclose